MCF Advisors’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Buy
155,130
+1,652
+1% +$34.5K 0.12% 100
2026
Q1
$3.21M Buy
153,478
+1,049
+0.7% +$22.2K 0.14% 83
2025
Q4
$3.22M Buy
152,429
+2,134
+1% +$45.2K 0.18% 60
2025
Q3
$3.19M Buy
150,295
+1,589
+1% +$33.5K 0.2% 45
2025
Q2
$3.13M Buy
148,706
+4,049
+3% +$83.6K 0.21% 43
2025
Q1
$3M Buy
144,657
+5,893
+4% +$121K 0.22% 40
2024
Q4
$2.82M Buy
138,764
+2,117
+2% +$43.8K 0.2% 42
2024
Q3
$2.9M Buy
136,647
+1,569
+1% +$32.7K 0.2% 37
2024
Q2
$2.74M Buy
135,078
+1,593
+1% +$32.1K 0.21% 38
2024
Q1
$2.74M Buy
133,485
+4,666
+4% +$95.4K 0.21% 39
2023
Q4
$2.68M Buy
128,819
+2,029
+2% +$40K 0.22% 40
2023
Q3
$2.46M Buy
126,790
+121,891
+2,488% +$2.43M 0.22% 42
2023
Q2
$99.3K Hold
4,899
0.01% 289
2023
Q1
$101K Hold
4,899
0.01% 283
2022
Q4
$97.5K Buy
+4,899
New +$97K 0.01% 278

Other funds holding IBDW

MCF Advisors's IBDW Position: Q2 2026 in Review

MCF Advisors increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 1.1% in Q2 2026, buying an estimated $34.5K and bringing the position to 155,130 shares worth $3.23M. The position accounts for 0.12% of the portfolio, ranked #100.

MCF Advisors first reported a position in IBDW in Q4 2022 and has held it in 15 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • MCF Advisors held 155,130 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $3.23M as of Q2 2026.
  • MCF Advisors bought 1,652 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $34.5K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.12% of MCF Advisors's portfolio in Q2 2026, its #100 holding.
  • MCF Advisors first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.